Frequently Asked Questions

Yes, we provide BRCA1/2 and CDKN2A mutation analysis for high-risk individuals.

Yes, follow-up care is crucial. Aster Hospitals provides comprehensive post-treatment support, including regular check-ups and rehabilitation services.

Recovery time varies but typically ranges from a few weeks to several months, depending on the extent of surgery and individual factors. Generally, hospital stays last 3–10 days, with initial recovery taking 4–8 weeks. Full recovery, including regaining cognitive and physical functions, may take months to a year. Rehabilitation, such as physical and speech therapy, may be needed. Follow-up care, including MRIs and monitoring, is crucial. Always consult a neurosurgeon for personalized recovery timelines and post-surgical care recommendations.

Yes, Aster Hospitals participates in clinical trials for innovative treatments like immunotherapy and targeted molecular therapies.

The survival rate for brain tumors depends on the type, location, and stage. For malignant brain tumors, the 5-year survival rate is around 36%, while for non-malignant tumors, it exceeds 90%. Glioblastomas have a lower survival rate of about 7%. Early detection and treatment improve outcomes.

While not all brain tumors are preventable, maintaining a healthy lifestyle and avoiding unnecessary radiation exposure may help reduce risk.

Aster Hospitals provide expert oncologists, cutting-edge treatments, personalized care, advanced robotic surgeries, and access to innovative clinical trials for better survival rates.

The 5-year survival rate is around 10%, but early-stage detection and advanced treatments improve prognosis significantly.

Risk can be reduced by avoiding smoking, maintaining a healthy diet, controlling diabetes, and limiting alcohol intake, but there is no guaranteed prevention.